{
  "page_summary": "This page provides an overview of molecular measurements commonly used in breast cancer, particularly focusing on estrogen receptor (ER) and progesterone receptor (PR) status and their associated scoring methods. It describes tests such as receptor positivity, proportion score, intensity score, and total score as factors in determining prognosis and treatment decisions, without defining any specific clinical efficacy endpoints.",
  "endpoint_candidates": []
}